Investing
U.S. drugmaker Mallinckrodt plans to file for bankruptcy protection
© Reuters.
(Reuters) – Mallinckrodt (OTC:) is planning to start bankruptcy proceedings in the coming days, the U.S. drugmaker said on Wednesday, as it struggles to make required settlement payments for lawsuits alleging that it helped fuel the U.S. opioid crisis.
The company has entered into a restructuring agreement, which will help it to reduce its total debt by about $1.9 billion.
One of the biggest manufacturers of opioid drugs, the company had emerged out of bankruptcy in 2022.
Read the full article here
-
Investing5 days ago
Hurricane Helene Hits Spruce Pine Mine, Quartz Used for Tech
-
Side Hustles6 days ago
5 Key Strategies for a Seamless Cloud Migration
-
Investing6 days ago
Israel stocks lower at close of trade; TA 35 down 0.23% By Investing.com
-
Side Hustles6 days ago
Why the Future of Cybersecurity Marketing Relies on Trust
-
Side Hustles5 days ago
VP Exec’s Top Tips for Negotiating and Relationship-Building
-
Passive Income6 days ago
Go Paperless with the PDF Reader Pro for $49.99
-
Side Hustles5 days ago
Why the Smallest Details Mean the Most in Marketing
-
Make Money4 days ago
The Top Employers and Opportunities for Part-Time Remote Jobs